David Moradi

CIK 1658843 · EXECUTIVE CHAIRMAN AND CPO · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.80M

Companies

2

Total Filings

21

Lifetime Open-Market Net

-$21.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AEYE EXECUTIVE CHAIRMAN AND CPO 2,806,712 $6.70 $18.80M -$22.69M 19 2026-05-06
HUMANIGEN, INC (KBIO) Delisted Director 778,210 $1.68M 2 2015-12-17

Recent Filings · Page 2 of 3

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-17 AEYE Buy (P) +6,340 $34.5K EDGAR
2023-01-24 AEYE Tax (F) −29,317 -$112.7K EDGAR
2022-05-24 AEYE Grant (A) +400,000 $0 EDGAR
2021-12-02 AEYE Buy (P) +98,716 $766.6K EDGAR
2021-08-23 AEYE Buy (P) +53,468 $612.5K EDGAR
2021-08-18 AEYE Buy (P) +100,464 $1.07M EDGAR
2021-03-12 AEYE Grant (A) +100,000 $0 EDGAR
2020-05-22 AEYE Grant (A) +58,274 $0 EDGAR
2019-12-10 AEYE Grant (A) +22,560 $0 EDGAR
2015-12-17 HUMANIGEN, INC (KBIO) Delisted Buy (P) +13,640 $399.9K EDGAR
Showing 1120 of 21
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.